
BMRN Technical Analysis Summary (NASDAQ)
Analyze BMRN on the NASDAQ with RSI, MACD, ADX, Bollinger Bands, support, resistance, momentum, and the latest technical trading signals.
Disclaimer for Technical Analysis Page
The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full DisclaimerBMRN Technical Analysis Summary (NASDAQ)
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) stock currently shows a neutral trend on the NASDAQ, supported by momentum and balanced buying pressure.
Technical conditions suggest BioMarin Pharmaceutical Inc. on the NASDAQ is awaiting a decisive move. Overall, BioMarin Pharmaceutical Inc. remains neutral, with indicators showing mixed momentum.
RSI (14): 55.66
Stochastic %K: 53.69
Williams %R: -30.83
Rate of Change (ROC): 2.07
Takeaway:BioMarin Pharmaceutical Inc. shows steady upward momentum, supported by improving signals.
MACD: 0.54
ADX: 16.42
ATR (14): 1.70
CCI (14): 86.92
Takeaway:BioMarin Pharmaceutical Inc. shows a neutral trend, with weak conviction and limited volatility.
Takeaway:BioMarin Pharmaceutical Inc. trades around the middle band, reflecting balanced price action.
Takeaway:BioMarin Pharmaceutical Inc. trades above the trend line, showing healthy momentum within the channel.
Overall Takeaway:BMRN shows bullish money flow, with volume and vigor supporting buyers.
Bullish Signals
RSI above 50 → positive momentum from buyers.
MACD above 0 → bullish trend confirmation.
Price trading above middle Bollinger Band → mid-term support intact.
MFI below 80 → room for more buying without overbought risk.
Bearish Signals
MACD below signal line → short-term caution on momentum.
Overall Recommendation:Technical indicators for BioMarin Pharmaceutical Inc. are mixed, suggesting a Hold or wait-and-see approach.